Hydroxychloroquine for Treatment of SARS-CoV-2 Infection? Improving Our Confidence in a Model-Based Approach to Dose Selection

Clin Transl Sci. 2020 Jul;13(4):642-645. doi: 10.1111/cts.12797. Epub 2020 May 9.

Authors

Samuel L M Arnold¹, Frederick Buckner¹

Affiliation

¹ Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington, Seattle, Washington, USA.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections* / drug therapy
Humans
Hydroxychloroquine
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Hydroxychloroquine